CLINICAL_TRIALS
trial_result
· 2017-02-14
Clinical Trial Update: Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients [Phase 2]
Summary
Phase 2 safety and pharmacokinetics update for Ifetroban in patients with Hepatorenal Syndrome, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cumberland Pharmaceuticals | Conditions: Hepatorenal Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-02-14